Methyl 3-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 97%, 5g

2-(4-(Benzyloxy)-3,5-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 25g

Sodium 1-Dodecanesulfonate>98.0%(T)5g

6-HYDROXY-3-PYRIDAZINECARBOXYLIC ACID MONOHYDRATE, 97.0%, 5g

Pyrrolidin-1-yl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone, 95.0%, 25g

4-Bromo-1-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-indole, 95%, 250mg

(1-((2-(Trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridin-2-yl)boronic acid, 95%, 100mg

2-Bromo-2'-nitroacetophenone, 98.0%, 25g

4-(4-Nitrofenilazo)-1-naftol, AR, 25 g, envase de vidrio

2-((E)-3-Ethoxy-2-methyl-allylidene)-malononitrile, 95.0%, 1g

Ethyl {[3-(trifluoromethyl)phenyl]carbamoyl}formate, 95+%, 250mg

6-Fluorosalicylaldehyde>98.0%(GC)(T)5g

2-(4-Bromo-1-methyl-1H-pyrazol-5-yl)ethanamine, 95.0%, 250mg